10-Q: Exponent Reports Q3 Revenue Growth, Boosts Share Buyback

Exponent, Inc. announced an 8% increase in third-quarter revenues and a 10% rise in diluted earnings per share, alongside an additional $100 million share repurchase authorization.

Summary

• Third-quarter 2025 revenues increased 8% to $147.12 million, with revenues before reimbursements up 10% to $137.073 million, compared to the same period last year.
• Diluted earnings per share for Q3 2025 rose to $0.55, up from $0.50 in the prior year's third quarter.
• Net income for Q3 2025 increased 8% to $28.044 million.
• For the nine months ended October 3, 2025, total revenues grew 3% to $434.589 million, but net income decreased 4.9% to $81.247 million, and diluted EPS fell 4.8% to $1.58.
• Operating income for the nine-month period decreased 1.8% to $90.647 million.
• Cash and cash equivalents decreased to $207.38 million as of October 3, 2025, from $258.901 million at January 3, 2025.
• Net cash used in financing activities significantly increased to $122.024 million for the nine months, primarily due to increased common stock repurchases totaling $72.712 million.
• The Board of Directors authorized an additional $100 million for common stock repurchases on October 30, 2025, adding to amounts remaining under prior authorizations.
• A cash dividend of $0.30 per share was approved on October 30, 2025, payable December 19, 2025, to stockholders of record as of December 5, 2025.

Sentiment

Score: 7

Explanation: The company demonstrated strong Q3 performance with revenue and EPS growth, and a significant new share repurchase authorization. However, the nine-month figures show a slight decline in overall profitability and operating cash flow, impacted by increased expenses and investments. The long-term lease commitment also presents a future cost increase. The overall sentiment is positive due to Q3 strength and shareholder return initiatives, but tempered by the nine-month trends and rising costs.

Positives

• Strong third-quarter revenue growth of 8% ($147.12 million) and 10% for revenues before reimbursements ($137.073 million).
• Third-quarter diluted EPS increased by 10% to $0.55, demonstrating strong quarterly profitability.
• Net income for the third quarter increased by 8% to $28.044 million.
• Overall billable hours increased 4% to 376,000 and utilization rose to 74% during Q3 2025.
• The Engineering and Other Scientific segment revenues grew 7.6% in Q3, driven by increased billable hours and billing rates, and operating income for this segment increased 13.7%.
• The Environmental and Health segment revenues grew 9.8% in Q3, driven by increased billing rates and regulatory consulting engagements, and operating income for this segment increased 11.7%.
• The Board authorized an additional $100 million for common stock repurchases on October 30, 2025, signaling confidence in the company's value and commitment to shareholder returns.
• Increased cash dividends declared per common share to $0.30 for Q3 2025 and $0.90 for the nine months ended October 3, 2025.

Negatives

• Nine-month net income decreased 4.9% to $81.247 million compared to the prior year.
• Nine-month diluted EPS decreased 4.8% to $1.58 compared to the prior year.
• Nine-month operating income decreased 1.8% to $90.647 million.
• Net cash provided by operating activities decreased by 13.9% for the nine months to $76.148 million.
• Significant increase in net cash used in financing activities, primarily due to increased common stock repurchases, leading to a net decrease in cash and cash equivalents.
• Rental income decreased significantly by $516,000 in Q3 and $1.809 million in 9M due to the loss of a tenant in the Silicon Valley facility.
• General and administrative expenses increased substantially (44.2% in Q3, 10.7% in 9M) partly due to a company-wide managers' meeting and higher relocation costs.
• Increased occupancy expense for the nine months due to the land lease extension with the State of Arizona, which will result in substantially higher annual payments ($6.183 million vs. $1.009 million) starting January 2028.
• Experienced a negative tax impact associated with stock-based awards for the nine months ($354,000 negative vs. $2.204 million positive last year).
• EBITDA as a percentage of revenues before reimbursements decreased for both the three-month (28.3% vs. 28.6%) and nine-month (27.8% vs. 29.3%) periods.

Risks

• Demand for services may decline as a result of changes in general and industry-specific economic conditions.
• The timing of engagements for services can fluctuate, impacting revenue recognition.
• The effects of competitive services and pricing could negatively impact profitability.
• The absence of backlog related to the business means future revenue is not guaranteed.
• The ability to attract and retain key employees is crucial for business operations and growth.
• The effect of tort reform and government regulation on the business and potential liabilities from claims made against the company.
• Fluctuations in foreign currency exchange rates, particularly for the British Pound, Euro, Chinese Yuan, and Hong Kong Dollar, could significantly impact future results of operations, especially with continued international growth.
• Actual results could differ from management's estimates and assumptions, particularly in accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts.
• The maximum potential amount of future payments under officer and director indemnification agreements is unlimited, although insurance coverage reduces exposure.

Future Outlook

Management expects compensation and other operating expenses to increase as the company selectively adds new talent and invests in corporate infrastructure. General and administrative expenses are also anticipated to rise with business development and staff development initiatives. The company believes its existing cash and cash generated from operations will be sufficient to meet working capital needs, capital expenditures, outstanding commitments, stock repurchases, dividends, and other liquidity requirements for at least the next twelve months. The company plans to continue investing, repurchasing shares, paying dividends, and pursuing strategic acquisitions.

Management Comments

• "We remain focused on building our world-class engineering and scientific team to position us at the forefront of innovation and meet the ever-changing needs of our clients and the market."
• "We also remain focused on capitalizing on emerging growth areas, managing other operating expenses, generating cash from operations, maintaining a strong balance sheet and undertaking activities such as share repurchases and dividends to enhance stockholder value."
• "We expect our compensation expense, excluding the change in value of deferred compensation plan assets, to increase as we selectively add new talent and adjust compensation to market conditions."
• "We expect other operating expenses to grow as we selectively add new talent and make investments in our corporate infrastructure."
• "We expect general and administrative expenses to increase as we add new talent and expand our business development and staff development initiatives."

Industry Context

Exponent operates in the engineering and scientific consulting sector, which is characterized by demand for specialized expertise in areas like dispute resolution, risk management, asset integrity, and regulatory compliance. The company's reported growth in reactive engagements across energy, transportation, life sciences, and construction, alongside proactive work in utilities and chemicals, suggests a robust and diversified demand for its niche services. However, lower activity in consumer electronics indicates some sector-specific fluctuations. The continued investment in talent and corporate infrastructure aligns with a strategy to maintain a competitive edge and adapt to evolving client needs in a knowledge-intensive industry.

Stakeholder Impact

• Shareholders: Positive impact from increased dividends and a substantial new share repurchase authorization, indicating management's commitment to returning capital. Potential for long-term value creation through strategic investments and talent acquisition.
• Employees: Continued focus on attracting and retaining key employees, with annual salary adjustments and increased bonus pools. Deferred compensation plans for highly compensated employees are maintained.
• Customers: Continued provision of solutions to complex problems, with growth in dispute-related work and proactive engagements, suggesting ongoing value delivery and client satisfaction.
• Creditors: The company maintains a strong balance sheet and believes it has sufficient liquidity, which is favorable for creditors. Assets in the rabbi trust for deferred compensation are subject to claims of creditors.

Next Steps

• Continue building the world-class engineering and scientific team.
• Capitalize on emerging growth areas.
• Manage other operating expenses effectively.
• Generate cash from operations and maintain a strong balance sheet.
• Undertake activities such as share repurchases and dividends to enhance stockholder value.
• Continue investing activities, including capital expenditures, particularly in corporate infrastructure.
• Strategically acquire professional service firms that are complementary to the business.
• Evaluate the effect of new accounting standards (ASU 2023-09 and ASU 2024-03) on consolidated financial statements and related disclosures.
• Pay the approved cash dividend of $0.30 per share on December 19, 2025.

Key Dates

Recommendation

While Exponent demonstrated strong Q3 revenue and EPS growth, and announced a significant new share repurchase program, the nine-month results show a slight decline in overall profitability and operating cash flow. The company is making strategic investments in talent and infrastructure, which are positive long-term drivers, but these are currently impacting short-term margins and cash generation. The increased future lease obligations also represent a notable fixed cost increase. Given the mixed performance across different periods and the ongoing investments, a 'hold' recommendation is appropriate. Investors should monitor the impact of these investments on future profitability and cash flow, as well as the effectiveness of the share repurchase program in enhancing shareholder value.

Keywords

Exponent, EXPO, Consulting, Engineering, Scientific Consulting, Environmental Health, Financial Results, Q3 2025, Earnings, Share Repurchase, Dividends, SEC Filing, 10-Q, Risk Management, Asset Integrity, Regulatory Consulting